清杉生命整合全球IVF、PGT-WGS全基因组胚胎筛查、专业胚胎跨境转运及合规第三方助孕服务,为您提供安全、合规、专业的全链条生育解决方案。
TsingShine Life Science integrates global IVF, PGT-WGS whole-genome embryo screening, professional cross-border embryo transport, and compliant third-party surrogacy — delivering a safe, legal, and comprehensive fertility solution from start to finish.
中国 · 日本 · 美国 · 加拿大 · 中亚
China · Japan · USA · Canada · Central Asia
恒温液氮冷链全程护送
Constant-temp LN₂ cold-chain escort
PGT-A · PGT-M · PGT-SR · PGT-P
满足各类家庭规划需求
Supporting all family-building needs
依托各地政策优势与顶尖医疗资源,为客户构建一站式跨境助孕解决方案。
Leveraging regional policy advantages and world-class medical resources to deliver seamless cross-border fertility solutions.
从基因检测到胚胎转运,从医疗协调到法律落户,清杉生命为您提供端到端的专业服务。
From genetic screening to embryo transport, from medical coordination to legal registration — TsingShine delivers end-to-end professional support at every step.
全面解析美、加、中亚地区合规代孕政策,提供爱心妈妈筛选、法律合同签约、孕期协调、出生纸和国外证件代办、回国落户指导等全流程服务。
We navigate surrogacy laws across the USA, Canada, and Central Asia — providing carrier matching, legal contracting, pregnancy coordination, birth certificate handling, and full repatriation guidance.
深入了解 →Learn More →−196°C恒温液氮冷链点对点陆运和空运,双向海关备案、无缝对接,专员全程合规护送,胚胎复苏率大于98%,安全可追溯。
Point-to-point land and air transport at −196°C in dry LN₂ dewars, with bilateral customs clearance, a dedicated compliance escort, and a survival rate exceeding 98% — fully traceable at every step.
深入了解 →Learn More →从PGT-A染色体整倍性筛查,到PGT-P多基因病风险评分(心脑血管、高血压、糖尿病等),到PGT-WGS全基因组检测,实现高端定制优生。
From PGT-A chromosomal screening to PGT-P polygenic risk scoring (cardiovascular disease, hypertension, diabetes, and more) to PGT-WGS whole-genome analysis — precision genetics, fully tailored.
深入了解 → Learn More →针对美国、加拿大、中亚三大区域,追踪各国现行立法,为客户定制符合当地法律的助孕方案。
We continuously track legislation across the USA, Canada, and Central Asia to craft surrogacy plans that are fully aligned with local law in each jurisdiction.
法律最完善 · 多元友好
Most robust legal framework · Inclusive
格鲁吉亚 · 吉尔吉斯斯坦Georgia · Kyrgyzstan
采用全球领先的干式液氮气相运输罐,专员全程护送,不接受X光扫描辐射,胚胎复苏率大于98%。
Using world-leading dry-vapor LN₂ dewars with a dedicated escort, zero X-ray exposure, and a post-thaw survival rate exceeding 98%.
从传统"疾病诊断"向"概率性遗传预测与优化"的范式跃迁。
A paradigm shift — from conventional disease diagnosis to probabilistic genetic prediction and optimization.
PGT-WGS是生殖医学检测的底层终极架构。相较于仅能筛查大片段染色体异常的传统PGT-A,全基因组测序能以高分辨率捕捉囊胚细胞数百万个SNP位点,获取胚胎完整基因图谱。
PGT-WGS is the ultimate foundation of reproductive genetic testing. Unlike conventional PGT-A — limited to large chromosomal abnormalities — whole-genome sequencing captures millions of SNP sites at high resolution, producing a complete genetic blueprint of every embryo.
一次测序,终生受益 — 完美兼容PGT-A、PGT-M、PGT-SR与PGT-P,真正实现无遗漏筛查。
One sequencing run, lifetime value — fully compatible with PGT-A, PGT-M, PGT-SR, and PGT-P for truly comprehensive, zero-gap screening.
同时检测全部23条染色体的整倍性、拷贝数变异及单基因遗传病,大幅拓展筛查维度。
Simultaneously assesses all 23 chromosomes for aneuploidy, copy-number variants, and single-gene disorders — dramatically expanding the scope of each screening cycle.
基于99.9%以上的遗传变异检测精度,明确区分健康胚胎与携带致病突变的胚胎。
With greater than 99.9% variant detection accuracy, healthy embryos are clearly distinguished from those carrying pathogenic mutations — supporting confident clinical decisions.
一次活检同时获取染色体状态与基因突变信息,最大限度减少对胚胎的物理干预。
A single biopsy simultaneously yields full chromosomal status and mutation data, minimizing physical stress on the embryo while maximizing the information obtained.
唯一能有效检测新发突变的技术,以95%以上精度识别自发产生的潜在遗传风险。
The only technology capable of reliably detecting de novo mutations — identifying spontaneously arising genetic risks with greater than 95% accuracy.
顶尖生殖医学专家与实验室,流程对中国客户极度友好,政策合规清晰。
World-class reproductive specialists and laboratories, a streamlined process for international clients, and a clear, compliant regulatory framework.
日本拥有全球领先的ART临床设施与实验室质控标准,纺锤体可视化等前沿技术广泛应用,为每一枚胚胎提供卓越的培养环境。
Japan offers globally leading ART clinical facilities and rigorous laboratory quality standards. Cutting-edge technologies such as spindle-view visualization are widely deployed, providing an exceptional culture environment for every embryo.
拥有多种个体化促排方案,全球领先的ART临床设施,纺锤体可视技术等前沿应用。
Individualized ovarian stimulation protocols, globally leading ART clinical facilities, and frontier techniques including spindle-view technology for superior embryo assessment.
中日距离近、零时差、出行便利,支持中日联合促排卵,对时间紧或无法获得美加签证的客户极为合适。
Close proximity, no time-zone difference, and easy travel. Combined China–Japan stimulation cycles are supported, making Japan ideal for clients with tight schedules or visa restrictions.
单亲生育、冻卵、基因匹配、胚胎跨境转运和接受均为合法,政策框架清晰可依。
Single-parent fertility, egg freezing, genetic matching, and cross-border embryo transfer are all legally permitted — offering a clear and dependable policy framework for international clients.
清杉生命与美国、欧洲、日本等地持牌精子库及卵子库合作,所有捐献者均通过多项医学与遗传学检测,严格遵循当地法律法规。
TsingShine partners with licensed sperm and egg banks across the USA, Europe, and Asia. All donors undergo comprehensive medical and genetic screening in strict compliance with local regulations.
来自欧美及亚洲持牌精子库
Licensed banks in the USA, Europe & Asia
来自欧美及亚洲合规捐卵机构
Compliant agencies in the USA, Europe & Asia
需求评估
医学咨询
Needs Assessment
& Medical Consult
供体库筛选
匿名档案匹配
Donor Bank Search
Anonymous Match
法律合同
知情同意签署
Legal Contract
& Informed Consent
配子获取
转运与使用
Gamete Retrieval
Transport & Use
合作来源地区(均为当地持牌合规机构)
Partner regions — all licensed and fully compliant institutions
每一个家庭的情况都是独特的。以下是清杉生命团队处理过的真实复杂病例,展示我们在高难度场景下的专业能力与全链条应对能力。
Every family's situation is unique. The following cases showcase TsingShine's expertise in handling high-complexity scenarios with full end-to-end coordination across borders.
从4次试管失败阴霾中走出,团队紧急启动应急预案,最终帮助46岁高龄患者实现平稳孕程突破。
After four failed IVF cycles, our team activated an emergency backup plan — successfully guiding a 46-year-old patient through a stable pregnancy to a healthy delivery.
46岁高龄患者卵巢功能严重退化,曾经历4次常规试管失败;配偶确诊重度弱精及无精症,常规取精路径面临根本性阻碍,生育希望渺茫。
A 46-year-old patient with severely diminished ovarian reserve had already undergone four failed IVF cycles. Her partner was diagnosed with severe oligospermia and azoospermia, eliminating all conventional sperm retrieval options and leaving little apparent hope for conception.
2025年1月于吉尔吉斯斯坦诊疗中心,在取精当日突发无可用精子的危机。医疗团队当即终止原方案,无缝切换至成熟的"第三方配子调配"B计划,确保周期不中断。
In January 2025, at a clinic in Kyrgyzstan, no viable sperm was obtained on retrieval day. The team immediately aborted the original protocol and seamlessly activated a pre-prepared donor gamete plan, keeping the cycle on track without interruption.
通过精准的配子培育,成功筛选获得3颗健康优质胚胎。于次月完成移植,截至目前,患者已成功生产一名健康女婴。
Through precise gamete culture and selection, three high-quality embryos were obtained. Transfer was completed the following month. The patient has since delivered a healthy baby girl.
打破地理与签证壁垒,通过多地分中心无缝协同调度,将看似不可能的跨境生育难题转化为可复制的成功路径。
Breaking through geographic and visa barriers via seamless multi-center coordination — transforming what seemed like an impossible cross-border fertility challenge into a replicable success story.
34岁贾女士家庭面临跨国生育阻碍,配偶出境受限且自身赴美签证遭遇拒签,常规赴美试管路径完全受阻,生育计划陷入停滞僵局。
Ms. Jia, 34, faced insurmountable cross-border obstacles: her partner was unable to travel abroad, and her own US visa application was denied — completely blocking the conventional IVF-in-America route and halting the family's fertility plan entirely.
成功完成两次高标准冻精储备,在患者接受重大生命维持手术前,完整守护了其生育自主权与构建家庭的未来可能性。
Two high-standard sperm cryopreservation sessions completed before the life-critical surgery — fully preserving the patient's reproductive autonomy and his family's future possibilities.
34岁已婚未育患者确诊晚期尿毒症,需长期透析维持。术后终身免疫抑制剂治疗将对睾丸生精功能及精子DNA造成不可逆的毁灭性损伤。
A 34-year-old married patient without children was diagnosed with end-stage uremia requiring long-term dialysis. Post-transplant, lifelong immunosuppressive therapy would cause irreversible, catastrophic damage to testicular spermatogenic function and sperm DNA integrity.
精准把握换肾术前的宝贵时间窗口,医疗团队与临床检验科建立绿色通道,通过快速评估与分次取精,高效完成高质量精子的优选与程序化冷冻保存。
The critical pre-surgery window was identified and seized. A fast-track interdisciplinary pathway was established, enabling rapid assessment, staged sperm retrieval, and programmatic cryopreservation of the highest-quality sperm obtained.
手术前完成两次取精与冷冻储存,建立充足精子库存。患者术后顺利恢复,生育计划得以完整延续,为日后辅助生殖治疗奠定坚实基础。
Two retrieval and freezing sessions were completed before surgery, establishing a robust sperm reserve. The patient recovered well post-transplant, with the fertility plan fully intact and a solid foundation in place for future ART treatment.
周期获卵19枚,经PGS筛查最终优选出5枚高等级健康囊胚,已建立完整档案,无缝衔接后续第三方辅助生殖移植计划。
19 oocytes retrieved; 5 top-grade healthy blastocysts selected following PGS screening. Full documentation established, seamlessly linking to the subsequent third-party surrogacy transfer plan.
33岁患者先天子宫阴道严重缺失,早年已行重建塑形术。基础卵巢储备极佳,AMH值达5.9ng/mL,窦卵泡计数(AFC)高达21个,生育潜力储备充足。
A 33-year-old patient with congenital absence of the uterus and vagina had undergone reconstructive surgery in earlier years. Despite this, her ovarian reserve was excellent: AMH 5.9 ng/mL and AFC 21 — indicating abundant fertility potential.
2024年6月于美国启动特制高抗排卵阻断方案。临床团队重点攻克了术后重建阴道透声视野差的难题,通过超声引导下的精细操作,成功实现了精准、安全的取卵全流程。
A specialized high-antagonist stimulation protocol was initiated in the USA in June 2024. The clinical team overcame poor ultrasound visibility through the reconstructed vaginal canal, achieving a precise and safe egg retrieval procedure under careful ultrasound guidance.
19枚获卵经PGS基因筛查,优选出5枚高等级健康囊胚并建立完整档案。患者已与清杉团队确认后续代孕方案,全周期生育闭环规划正式启动。
All 19 oocytes were screened by PGS; 5 top-grade healthy blastocysts were selected and fully documented. The patient has confirmed her surrogacy plan with the TsingShine team — the complete fertility cycle roadmap is now formally underway.
清杉生命创立于2016年,是一家专注全球辅助生殖技术应用的专业医学技术机构。公司以优生优育为核心导向,聚焦客户多元化需求,不仅可定制专属生育方案,更能针对复杂生殖病例整合全球优质医疗资源提供一站式解决方案。
Founded in 2016, TsingShine Life Science is a specialist medical technology firm dedicated to global assisted reproductive technology. With optimized fertility outcomes at the core of everything we do, we tailor bespoke plans for every client and integrate world-class resources to address even the most complex reproductive cases.
技术、合规、流程、支持——是清杉生命对每一个家庭的承诺。
Technology, compliance, process, and support — TsingShine's promise to every family.
首批将PGT-WGS应用于常规临床筛查的助孕服务体系之一,为每一枚胚胎提供超越传统的遗传学评估,一次测序、终生受益。
Among the first to apply PGT-WGS in routine clinical screening, we provide every embryo with beyond-conventional genetic assessment — one sequencing run delivering a lifetime of benefit.
深耕美、加、中亚两大市场的法规环境,以合规为底线构建服务体系,确保客户在每个环节都享有完整的法律保障。
With deep expertise across the regulatory environments of the USA, Canada, and Central Asia, compliance is our non-negotiable baseline — ensuring clients enjoy full legal protection at every stage.
从取卵、胚胎培养、遗传筛查到跨境转运与第三方助孕,以一体化流程将各个环节紧密串联,消除信息孤岛与衔接断层。
From egg retrieval and embryo culture to genetic screening, cross-border transport, and surrogacy — every step tightly integrated within a single coordinated process, eliminating information gaps and handoff failures.
从法律咨询、爱心妈妈筛选匹配、合同签署、医疗协调到亲权确认与子女归国手续,提供端到端的专业陪伴。
From legal consultation, gestational carrier matching, and contract signing to medical coordination, parental rights confirmation, and child repatriation — dedicated professional support from the very first step to the last.
我们以最严谨的态度对待每一次托付
与您共同遇见健康的未来
We approach every case with the utmost care and precision.
Together, let's welcome a healthy future.
电邮:Email: guoqin.lin@huiivf.com
公司地址:Address: Unit #1608, 5th Joseph St
Toronto, Ontario M4Y 0B6, Canada